About
Technology
Issues
FAQ
Links
Official Page
A phase I pharmacokinetics trial comparing PF‐05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.